BioStock: Neola Medical continues towards market approval

2022 was an intense year for Lund-based Neola Medical. A change of name was combined with positive clinical results, ISO certification and a successful capital raise. The company is now working to prepare the Neola lung monitoring system for launch in the US. BioStock contacted CEO Hanna Sjöström for  a comment on the year-end report released this week.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/02/neola-medical-continues-towards-market-approval/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se